financetom
Business
financetom
/
Business
/
SciSparc Stock Shoots Up Over 89% After Hours: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
SciSparc Stock Shoots Up Over 89% After Hours: What's Going On?
Sep 16, 2025 8:14 PM

SciSparc Ltd. ( SPRC ) shares soared 89.13% to $3.48 during after-hours trading on Tuesday, following news of a court-granted stay in merger proceedings with AutoMax Motors Ltd. (TLV: AMX). The dramatic surge came after regular trading closed at $1.84.

Check out the current price of SPRC stock here. 

Court Grants Stay Until September 30

The Jerusalem District Court has granted AutoMax’s request to delay merger proceedings until September 30, according to an SEC filing by SciSparc ( SPRC ). AutoMax, which specializes in manufacturing automotive solutions, asked for the postponement due to concerns about its ability to complete the merger and challenges in meeting the closing conditions following recent business developments.

See Also: Tesla, Warner Bros. Discovery Get Partial Victory In AI Image Lawsuit From ‘Blade Runner’ Production Company

Merger Agreement Background

The companies signed a merger agreement on April 10, 2024, which has since been revised. SciSparc ( SPRC ) had previously submitted a Form 6-K report on September 8, explaining issues in the deal, including operational difficulties at AutoMax.

Technical Analysis and Market Impact

In 2025, the stock of the  Israel-based company saw a significant decline of 75.66%, with its highest point on January 6 at $22.47 and a volume of 191 million shares. By Monday, the price had reached its low of $1.80, with a trading volume of just 123,000 shares, well below the average daily volume of 705,530 shares.

With a market capitalization of $2.98 million, SPRC has traded between $1.75 and $37.59 over the past year. The stock remains down 71.87% over the past year, despite Monday’s after-hours surge.

Price Action: According to the Benzinga Pro data, SPRC experienced a surge of 2.22% during the regular trading session on Tuesday.

Read Next: Shiba Inu Could Surge 3,000% and Overtake Dogecoin by 2026, Say Analysts

Benzinga’s Edge Stock Rankings highlight the biopharmaceutical company has a negative price trend across all time frames. Track the performance of other players in this segment.

Read Next:

Berlin Gaming Startup Born Raises $15M From Tencent, Accel To Combat Loneliness With AI ‘Friends’ That 15M Users Love

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Market Chatter: Swiss Financial Regulator Intends to Block Investors Accessing Credit Suisse AT1 Files
Update: Market Chatter: Swiss Financial Regulator Intends to Block Investors Accessing Credit Suisse AT1 Files
Apr 4, 2024
11:05 AM EDT, 04/04/2024 (MT Newswires) -- (Updates with UBS response in the seventh paragraph.) Switzerland's financial regulator is seeking to block the release of certain documents to investors for not accessing Credit Suisse tier 1 bonds, the Financial Times reported Thursday, citing a letter from the Swiss Financial Market Supervisory Authority to the Swiss Federal Administrative Court last month....
Henry Schein Closes Acquisition of Majority Stake in TriMed
Henry Schein Closes Acquisition of Majority Stake in TriMed
Apr 4, 2024
11:03 AM EDT, 04/04/2024 (MT Newswires) -- Henry Schein (HSIC) said Thursday it closed its acquisition of a majority stake in orthopedic company TriMed. Financial terms weren't disclosed. TriMed develops solutions for the orthopedic treatment of foot, ankle, hand and wrist. Henry Schein said it expects the acquisition to be neutral to 2024 non-GAAP per-share earnings and accretive afterwards. Price:...
Allarity Therapeutics to Implement 1-for-20 Reverse Stock Split
Allarity Therapeutics to Implement 1-for-20 Reverse Stock Split
Apr 4, 2024
11:02 AM EDT, 04/04/2024 (MT Newswires) -- Allarity Therapeutics ( ALLR ) said Thursday it plans to implement a 1-for-20 reverse split of its common shares to regain compliance with Nasdaq's minimum bid price requirement. The company expects its shares to start trading on a split-adjusted basis Tuesday. Allarity Therapeutics ( ALLR ) shares were up 2.4% in recent Thursday...
AAR Signs Multiyear Distribution Deal With Triumph Unit
AAR Signs Multiyear Distribution Deal With Triumph Unit
Apr 4, 2024
10:59 AM EDT, 04/04/2024 (MT Newswires) -- AAR (AIR) said Thursday that it signed a multiyear commercial distribution agreement with Triumph Group's ( TGI ) Actuation Products & Services unit to exclusively distribute Triumph's commercial actuation product line beginning in January 2026. The deal complements AAR's current product offerings and customer base, the company said. Financial terms were not disclosed....
Copyright 2023-2026 - www.financetom.com All Rights Reserved